EGFR and lung cancer: PERTINENT FINDINGS: In brain, head-and-neck, and lung cancer patients, cellular EGFR expression, tumor cell density, plasma antibody concentration, and delivery barrier predicted the heterogeneous intratumoral antibody distribution, whereas open-field imaging device settings, lighting conditions, and tumor size and depth substantially influenced the macroscopic fluorescence contrast.